Last modified: Thursday, December 9, 2010
Indiana CTSI to host third annual Purdue retreat
FOR IMMEDIATE RELEASE
Dec. 9, 2010
INDIANAPOLIS -- The Indiana Clinical and Translational Sciences Institute (CTSI) will host its third annual retreat, this one titled "Advancing the Science of Translational Medicine," on Dec. 17 at Purdue University.
Indiana CTSI Director Anantha Shekhar, M.D., will present the opening address at the institute's third annual retreat, set for Dec. 17.
The retreat will present scientific advances and success stories that highlight translational research collaborations among Indiana University, Purdue University and the University of Notre Dame. Opening addresses will include an update from Indiana CTSI Director Anantha Shekhar, M.D., and deputy director Connie Weaver, the distinguished professor and director of the Department of Foods and Nutrition, Purdue University, who will discuss future perspectives of the Indiana CTSI.
The retreat will run from 8 a.m. to 5 p.m. Friday, Dec. 17, at the Discovery Learning and Research Center, room 131, located at 207 S. Martin Jischke Drive, Suite 203, West Lafayette.
The morning session will feature an update on advances in biomedical engineering and bionanotechnology from George Wodicka, professor of electrical and computer engineering at Purdue University. Also presenting will be Rachel Vreeman of the IU School of Medicine, Purdue professor of veterinary pathology William Van Alstine, and Lynetta Freeman, Purdue associate professor of small animal surgery. A. Steven Frankel, a professor of mechanical engineering at Purdue, will be among investigators presenting research success stories from the Indiana CTSI Project Development Team program.
The afternoon session will begin with a discussion on bionutrition, including Wayne Campbell, a Purdue professor of foods and nutrition, and Sophie Lelievre, a Purdue associate professor of basic medical sciences. Additional sessions include talks by Yunlong Liu and Marcus Breese, IU School of Medicine, on next generation sequencing, and Eric Davis, president and CEO of Kylin Therapeutics Inc., who will discuss the various challenges of commercializing research discoveries.
Afternoon breakout sessions will promote discussions on implementing research, and data management and sharing. Also scheduled are a lunchtime poster presentation in the heart of Discovery Park and an afternoon town-hall meeting titled "How we can make the most of the Indiana CTSI."
The retreat is designed to generate dynamic discussions and scientific deliberations dedicated to advancing the science of translational medicine. For more information, see the event flier. Lunch will be served. To register, please visit www.indianactsi.org/workshops/puretreatdec2010.
Indiana CTSI is a statewide collaboration of Indiana University, Purdue University and the University of Notre Dame, as well as public and private partnerships, which facilitates the translation of scientific discoveries in the lab into clinical trials and new patient treatments in Indiana and beyond. It was established in 2008 with a $25 million Clinical and Translational Science Award from the National Center for Research Resources of the National Institutes of Health, together with nearly $60 million from the state, the three member universities, and public and private donors. Indiana CTSI is a member of a national network of 55 CTSA-funded organizations across the United States.
For more information, please contact Steve Chaplin, University Communications, at 812-856-1896 or stjchap@indiana.edu, or Kevin Fryling, communications specialist, Indiana CTSI, at 317-278-0088 or kfryling@iupui.edu.
